GREY:AMRSQ - Post by User
Post by
jthottamon Dec 18, 2021 2:12am
369 Views
Post# 34242933
IDRI Contract with BARDA (potential opportunity for AMRS)
IDRI Contract with BARDA (potential opportunity for AMRS) Update: Amyris (Ticker: AMRS)
The following was published by Infection Disease Research Institue ("IDRI") whom AMRS has an exclusive license for an RNA vaccine platform.
https://www.idri.org/wp-content/uploads/2021/12/IDRI-BARDA-Award-Release_12.14.21.pdf
The Biomedical Advanced Research and Development Authority ("BARDA"), a U.S. Department of Health and Human Services office responsible for the procurement and development of medical countermeasures, has contracted with IDRI to develop an intranasally delivered RNA vaccine for pandemic influenza.
While the piece does not specifically mention AMRS, we do know AMRS was previously involved with intranasal delivered RNA research and AMRS also can provide the adjuvent for lower cost and sustainable manufacturing for the vaccine.
While this is a 2 year contract with IDRI, I suspect this is another seed of opportunity/optionality for AMRS further down the road.
Happy Holidays and Happy Investing!